Opportunity Information: Apply for RFA NS 24 034

This NIH funding opportunity (RFA-NS-24-034) supports an Alzheimer s disease-related dementias (ADRD) initiative focused on creating practical, shareable tools and resources that help researchers interpret in vivo neuroimaging findings linked to vascular injury and dysfunction. The central scientific goal is to better explain the vascular pathophysiology that underlies imaging features commonly associated with vascular contributions to cognitive impairment and dementia (VCID), with an emphasis on TBI-related dementia as well as other ADRD diagnoses. In plain terms, the program is trying to close the gap between what clinicians and researchers see on scans in living people and what those findings actually mean biologically when compared against human neuropathology, so that imaging markers can be understood more accurately and used more effectively across studies and clinical contexts.

The award uses the U24 cooperative agreement mechanism, which typically means NIH will have substantial programmatic involvement and expects the funded group to operate as a resource builder and distributor for the field rather than running a traditional hypothesis-driven research project. Clinical trials are not allowed under this announcement, so applications should be structured around technology and resource development, standardization, validation, and dissemination instead of testing an intervention in humans. The kinds of outputs NIH is looking for include innovative technologies, methods, protocols, and biomedical materials that make it easier to conduct combined neuropathology and neuroimaging studies, generate high-quality data, and interpret clinically relevant imaging signals through a neuropathologically informed lens. A strong application would usually describe what will be built, how it will be tested for robustness and usability, how it will be documented, and how the broader community will access and adopt it.

A major program expectation is open data sharing and broad distribution. Resources developed under the FOA are intended to expand the overall research community s capacity, not just the awardee s lab or consortium. That implies deliverables such as well-documented pipelines, standardized acquisition or processing protocols, reference datasets, harmonized ontologies, tissue handling and imaging-to-pathology alignment procedures, quality control frameworks, or other community-facing materials that can be reused across institutions. Because the opportunity is explicitly about understanding the pathophysiology behind in vivo imaging findings tied to VCID and related processes, the work should make a clear connection between imaging observations and vascular mechanisms supported by human neuropathology evidence, enabling more confident interpretation of ARIA- and VCID-relevant neuroimaging signatures in living participants.

Eligibility is broad and includes many U.S.-based organization types: state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other eligible entities. The announcement also highlights additional eligible applicant categories such as HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and AANAPISIs, along with faith-based or community-based organizations and eligible federal agencies. Foreign organizations are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible; however, foreign components as defined by NIH policy are allowed, meaning certain well-justified international collaborations or activities may be permissible when structured as a foreign component under NIH rules.

Key administrative details include that the sponsoring agency is the National Institutes of Health, the funding instrument is a cooperative agreement, and the activity category is health. The CFDA numbers listed are 93.853 and 93.866. The original closing date provided is 2024-06-02, the opportunity was created on 2024-03-28, and the award ceiling is noted as $1,000,000. Overall, the opportunity is best understood as NIH investing in field-building infrastructure: reusable, openly shared tools and standardized resources that let many groups connect neuroimaging findings to underlying vascular biology in ADRD and TBI-related dementia research, improving interpretation, comparability, and scientific traction across studies.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in ARIA (U24 - Clinical Trials Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.866.
  • This funding opportunity was created on 2024-03-28.
  • Applicants must submit their applications by 2024-06-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA NS 24 034

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the main goal of NIH RFA-NS-24-034?

The opportunity supports an Alzheimer s disease-related dementias (ADRD) initiative to create practical, shareable tools and resources that help researchers interpret in vivo neuroimaging findings related to vascular injury and dysfunction. The broader aim is to close the gap between what is seen on brain scans in living people and what those imaging findings mean biologically when compared against human neuropathology, especially for vascular contributions to cognitive impairment and dementia (VCID).

What scientific problem is this program trying to solve?

This program focuses on improving how the field explains the vascular pathophysiology underlying neuroimaging features commonly associated with VCID. In practical terms, it is about making neuroimaging markers more interpretable and comparable by connecting imaging observations to vascular mechanisms supported by human neuropathology evidence.

Which disease areas and populations are emphasized?

The initiative is centered on ADRD with a focus on VCID-relevant processes, with explicit emphasis on TBI-related dementia as well as other ADRD diagnoses.

What is the funding mechanism for this opportunity?

The award uses the U24 cooperative agreement mechanism. This generally signals substantial NIH programmatic involvement and an expectation that the funded group will operate as a resource builder and distributor for the broader research community, rather than running a traditional hypothesis-driven research project.

Are clinical trials allowed under this FOA?

No. Clinical trials are not allowed. Applications should be structured around technology and resource development, standardization, validation, and dissemination, rather than testing an intervention in humans.

What kinds of deliverables is NIH looking for?

NIH is looking for community-facing outputs such as innovative technologies, methods, protocols, and biomedical materials that make it easier to conduct combined neuropathology and neuroimaging studies, generate high-quality data, and interpret clinically relevant imaging signals through a neuropathologically informed lens.

Can you give examples of resources that fit the intent of the program?

Examples explicitly aligned with the program expectations include well-documented pipelines; standardized acquisition or processing protocols; reference datasets; harmonized ontologies; tissue handling and imaging-to-pathology alignment procedures; and quality control frameworks or other reusable materials that can be adopted across institutions.

How should an application show that the outputs will be useful to others?

Based on the program description, a strong application would typically spell out what will be built, how it will be tested for robustness and usability, how it will be documented, and how the broader community will access it and adopt it.

Is open sharing of data and resources expected?

Yes. A major expectation is open data sharing and broad distribution. The resources are intended to expand the overall research community s capacity, not just the awardee s lab or consortium.

What does it mean that this is a field-building infrastructure investment?

It means NIH is prioritizing reusable, openly shared tools and standardized resources that many research groups can use to connect neuroimaging findings to underlying vascular biology in ADRD and TBI-related dementia research. The intended impact is improved interpretation, comparability, and scientific traction across studies.

What must the work connect neuroimaging findings to?

The work should make a clear connection between imaging observations and vascular mechanisms supported by human neuropathology evidence. The goal is to enable more confident interpretation of ARIA- and VCID-relevant neuroimaging signatures in living participants.

Who is eligible to apply?

Eligibility is broad for U.S.-based organizations and includes state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other eligible entities.

Are specific institution types encouraged or highlighted as eligible?

Yes. The announcement highlights additional eligible applicant categories such as HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and AANAPISIs, along with faith-based or community-based organizations and eligible federal agencies.

Are foreign organizations eligible to apply?

No. Foreign organizations are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible.

Are any international collaborations allowed?

Yes, in a limited way. Foreign components (as defined by NIH policy) are allowed, meaning certain well-justified international collaborations or activities may be permissible when structured as a foreign component under NIH rules.

What is the sponsoring agency and funding instrument?

The sponsoring agency is the National Institutes of Health (NIH). The funding instrument is a cooperative agreement.

What is the activity category for this opportunity?

The activity category is health.

What CFDA numbers are associated with this funding opportunity?

The CFDA numbers listed are 93.853 and 93.866.

What is the application closing date listed for this opportunity?

The original closing date provided is 2024-06-02.

When was the opportunity created?

The opportunity was created on 2024-03-28.

What is the award ceiling listed in the opportunity summary?

The award ceiling is noted as $1,000,000.

Is this opportunity mainly for running a research study or building shared resources?

Based on the description, it is primarily aimed at building and distributing shared resources for the field (tools, standards, methods, and related materials), with emphasis on validation, usability, and dissemination, rather than running a traditional hypothesis-driven study.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed)

Previous opportunity: FY24 IIJA/IRA Bureau of Land Management Nevada (NV) Plant Conservation and Restoration Management

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA NS 24 034

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA NS 24 034) also looked into and applied for these:

Funding Opportunity
Maximizing Access to Research Careers (MARC) (T34) Apply for PAR 24 138

Funding Number: PAR 24 138
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) Apply for PAR 24 137

Funding Number: PAR 24 137
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
GH Social and Behavior Change (SBC) Activity Apply for 7200AA24RFA00008

Funding Number: 7200AA24RFA00008
Agency: Agency for International Development
Category: Health
Funding Amount: $321,500,000
Research to Advance the Science of Primary Care (R01) Apply for PA 24 205

Funding Number: PA 24 205
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed) Apply for RFA AI 24 019

Funding Number: RFA AI 24 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed) Apply for RFA AI 24 021

Funding Number: RFA AI 24 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed) Apply for RFA AI 24 020

Funding Number: RFA AI 24 020
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) Apply for PAR 24 172

Funding Number: PAR 24 172
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,515,000
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) Apply for PAR 24 173

Funding Number: PAR 24 173
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
USAID Kenya and East Africa (KEA) Social and Behavior Change (SBC) Activity Apply for 72061524RFA00004

Funding Number: 72061524RFA00004
Agency: Kenya USAID-Nairobi
Category: Health
Funding Amount: $14,950,000
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) Apply for RFA TR 24 023

Funding Number: RFA TR 24 023
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional) Apply for RFA MH 25 190

Funding Number: RFA MH 25 190
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 24 006

Funding Number: RFA RM 24 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) Apply for RFA TR 24 021

Funding Number: RFA TR 24 021
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 - Clinical Trial Not Allowed) Apply for PAR 24 196

Funding Number: PAR 24 196
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed) Apply for RFA AI 24 013

Funding Number: RFA AI 24 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required) Apply for PAR 24 168

Funding Number: PAR 24 168
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Amyloid Beta Immunotherapy (R01 - Clinical Trial Not Allowed) Apply for PAR 24 198

Funding Number: PAR 24 198
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed) Apply for PAR 24 203

Funding Number: PAR 24 203
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) Apply for PAR 24 139

Funding Number: PAR 24 139
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 24 034", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: